GE HealthCare Techs Q2 2024 Adj. EPS $1.00 Beats $0.98 Estimate, Sales $4.839B Miss $4.872B Estimate
Portfolio Pulse from Benzinga Newsdesk
GE HealthCare Technologies reported Q2 2024 adjusted EPS of $1.00, beating the estimate of $0.98. However, sales were $4.839 billion, missing the estimate of $4.872 billion.
July 31, 2024 | 10:21 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
GE HealthCare Technologies reported Q2 2024 adjusted EPS of $1.00, beating the estimate of $0.98. However, sales were $4.839 billion, missing the estimate of $4.872 billion.
The mixed results, with EPS beating estimates but sales missing, may lead to a neutral short-term impact on GEHC's stock price. Investors may weigh the positive EPS against the sales miss.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100